[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632025":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":22,"responsibleParty":39,"collaborators":7,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":7,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":7,"studyType":54,"phases":7,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":24,"whyStopped":7,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"European Institute of Oncology","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Marta Tagliabue, MD","Istituto Europeo di Oncologia","PRINCIPAL_INVESTIGATOR",[14,18],{"name":10,"role":15,"phone":16,"phoneExt":7,"email":17},"CONTACT","00390257489405","marta.tagliabue@ieo.it",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},"francesca lombardi","00390257489425","francesca.lombardi@ieo.it",[23],{"facility":5,"status":24,"city":25,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"RECRUITING","Milan","MI","20141","Italy","IT",{"type":31,"coordinates":32},"Point",[33,34],9.18951,45.46427,{"lat":34,"lon":33},[37],{"name":10,"role":15,"phone":38,"phoneExt":7,"email":17},"00390257489495",{"type":40,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100632025","role-of-the-immune-system-in-preventing-laryngeal-cancer-100632025",false,"NCT07508319","Role of the Immune System in Preventing Laryngeal Cancer","Laryngeal Dysplasia and Progression to Carcinoma: Investigating Genetic and Immune Alterations Predictive of Malignant Transformation","Inclusion Criteria:\n\n* Histopathological diagnosis of laryngeal dysplasia.\n* Age \\>18 years and informed consent.\n\nExclusion Criteria:\n\n* Prior surgical, radiotherapeutic, or oncologic treatments for head and neck regions.\n* Congenital or acquired immunodeficiency disorders.\n* Synchronous malignancies.\n* Immunosuppressive therapy.\n* Age \\\u003C18 years or absence of research consent.","ALL","18 Years","99 Years",{"count":52,"type":53},3,"ESTIMATED","OBSERVATIONAL","Laryngeal dysplasia and progression to carcinoma: investigating genetic and immune alterations predictive of malignant transformation",[57],"Head & Neck Cancer",[59],"Laryngeal dysplasia","2026-03-31",{"date":62,"type":63},"2026-04-02","ACTUAL",{"date":65,"type":63},"2025-11-19",{"date":67,"type":53},"2026-12-31",{"name":5,"class":6},1]